Skip to main content
Clinical Trials/NCT03612635
NCT03612635
Completed
Not Applicable

Impact on Patient Outcome and Healthcare Utilization of Cardiac ImplaNTable Electronic Devices Complications

Azienda Ospedaliera Cardinale G. Panico6 sites in 1 country2,811 target enrollmentJanuary 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Implantable Electronic Device Complications
Sponsor
Azienda Ospedaliera Cardinale G. Panico
Enrollment
2811
Locations
6
Primary Endpoint
All-cause Death (dead/alive status assessment during follow-up)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this registry is to evaluate the impact on patient outcome and on healthcare utilization of cardiac implantation electronic device complications during a long-term follow-up.

Detailed Description

Multicentric, observational, prospective registry enrolling consecutive patients underwent pacemaker or defibrillator implantation, aimed to evaluate the impact of cardiac implantable device complications requiring surgical revision on healthcare utilization (number and length of hospitalizations), and on patient outcome (all-cause mortality and cardiac mortality), during a long-term follow-up.

Registry
clinicaltrials.gov
Start Date
January 1, 2010
End Date
February 1, 2017
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Azienda Ospedaliera Cardinale G. Panico
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients underwent cardiac implantable electronic device implantation according to current guidelines during the enrollment period.

Exclusion Criteria

  • patients already carriers of a cardiac implantable electronic device underwent replacement or upgrading of device.

Outcomes

Primary Outcomes

All-cause Death (dead/alive status assessment during follow-up)

Time Frame: An average of 48 months

Evaluation of all-cause mortality during follow-up

Secondary Outcomes

  • Occurrence of hospitalizations related to cardiac implantable electronic device complications(An average of 48 months)

Study Sites (6)

Loading locations...

Similar Trials